Phibro Animal Health Corp (NASDAQ:PAHC) VP Daniel M. Bendheim sold 2,500 shares of the company’s stock in a transaction on Wednesday, September 12th. The stock was sold at an average price of $44.30, for a total transaction of $110,750.00. Following the sale, the vice president now directly owns 2,500 shares in the company, valued at $110,750. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link.

Shares of NASDAQ:PAHC traded down $0.35 on Friday, hitting $43.75. The company had a trading volume of 196,900 shares, compared to its average volume of 110,117. Phibro Animal Health Corp has a 1-year low of $32.05 and a 1-year high of $54.62. The company has a market cap of $1.81 billion, a P/E ratio of 25.19, a P/E/G ratio of 2.59 and a beta of 0.89. The company has a debt-to-equity ratio of 1.62, a current ratio of 2.90 and a quick ratio of 1.66.

Phibro Animal Health (NASDAQ:PAHC) last released its quarterly earnings data on Monday, August 27th. The company reported $0.46 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $0.42 by $0.04. Phibro Animal Health had a net margin of 7.90% and a return on equity of 39.81%. The firm had revenue of $211.80 million for the quarter, compared to the consensus estimate of $209.27 million. During the same period in the previous year, the company earned $0.39 earnings per share. The company’s quarterly revenue was up 8.7% on a year-over-year basis. equities research analysts expect that Phibro Animal Health Corp will post 1.8 earnings per share for the current year.

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, September 26th. Shareholders of record on Wednesday, September 5th will be issued a $0.10 dividend. The ex-dividend date of this dividend is Tuesday, September 4th. This represents a $0.40 annualized dividend and a dividend yield of 0.91%. Phibro Animal Health’s dividend payout ratio is currently 22.99%.

Large investors have recently added to or reduced their stakes in the business. Royal Bank of Canada increased its holdings in shares of Phibro Animal Health by 2,104.6% in the first quarter. Royal Bank of Canada now owns 3,814 shares of the company’s stock valued at $151,000 after purchasing an additional 3,641 shares during the last quarter. Meeder Asset Management Inc. increased its holdings in shares of Phibro Animal Health by 149.2% in the second quarter. Meeder Asset Management Inc. now owns 4,470 shares of the company’s stock valued at $206,000 after purchasing an additional 2,676 shares during the last quarter. Piedmont Investment Advisors LLC acquired a new position in shares of Phibro Animal Health in the second quarter valued at $213,000. Janus Henderson Group PLC acquired a new position in shares of Phibro Animal Health in the second quarter valued at $222,000. Finally, Highbridge Capital Management LLC acquired a new position in shares of Phibro Animal Health in the first quarter valued at about $214,000. Hedge funds and other institutional investors own 50.45% of the company’s stock.

Several analysts have issued reports on the stock. BidaskClub raised shares of Phibro Animal Health from a “hold” rating to a “buy” rating in a research report on Wednesday, August 8th. Morgan Stanley upped their price objective on shares of Phibro Animal Health from $36.00 to $46.00 and gave the company an “underweight” rating in a report on Wednesday, August 29th. Zacks Investment Research downgraded shares of Phibro Animal Health from a “hold” rating to a “sell” rating in a report on Wednesday, August 29th. Finally, Barclays upped their price objective on shares of Phibro Animal Health from $31.00 to $33.00 and gave the company an “underweight” rating in a report on Thursday, July 5th. Two investment analysts have rated the stock with a sell rating, two have issued a hold rating and three have assigned a buy rating to the company. The stock has an average rating of “Hold” and an average target price of $43.20.

About Phibro Animal Health

Phibro Animal Health Corporation operates as a diversified animal health and mineral nutrition company primarily in the United States. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets products for a range of food animals comprising poultry, swine, beef and dairy cattle, and aquaculture.

Featured Article: How to Calculate Compound Annual Growth Rate (CAGR)

Insider Buying and Selling by Quarter for Phibro Animal Health (NASDAQ:PAHC)

Receive News & Ratings for Phibro Animal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Phibro Animal Health and related companies with MarketBeat.com's FREE daily email newsletter.